BBOTVSNUS• 7 Days (Normalized)
BBOT vs NUS (BridgeBio Oncology Therapeutics Inc. vs Nu Skin Enterprises Inc.)
Showing Closing Date Range from Sep 30 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.44
-16.1%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NUS Performance $4.8
+4.12%
Nu Skin Enterprises Inc.
Normalized Baseline0.00%
Alpha Spread Margin NUS LEADS
-20.22 pts
NUS outperforming by 20.22 percentage points
BBOTNUS
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NUS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BBOT Price | BBOT Gain (%) | NUS Price | NUS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $3.44 | -16.10% | $4.80 | +4.12% | -20.22% |
| Oct 06, 2026 | $3.50 | -14.63% | $4.74 | +2.82% | -17.45% |
| Oct 05, 2026 | $3.60 | -12.20% | $4.63 | +0.43% | -12.63% |
| Oct 02, 2026 | $3.89 | -5.12% | $4.61 | +0.00% | -5.12% |
| Sep 30, 2026 | $4.10 | +0.00% | $- | - |